	Multi-omic biomarker detection in UV-induced melanoma. Clin Chim Acta Alqahtani SM, Afzal M, Afzal O, Alabbas A, Phalak P, Goyal K. PMID: 41692134 [PubMed - as supplied by publisher]
	Determinants of adjuvant treatment choice between immunotherapy (immune checkpoint inhibitor) and targeted therapy in resected stage III BRAF V600-mutated cutaneous melanoma: a multicenter observational study: MELADJ3. Melanoma Res Devoldere A, Bouche O, Barbe C, Didier K, Colbach S, Brocard FG, Carlier C. PMID: 41691529 [PubMed - as supplied by publisher]
	Parkinson's disease and risk of melanoma in United States Veterans: A Veterans Affairs Cancer Registry retrospective cohort study. J Am Acad Dermatol Hwang JC, Huhmann LB, Perez D, Kim DY, Nannini K, Do NV, Gaziano JM, Brophy MT, Wheless LE, Fillmore NR, Hartman RI. PMID: 41690486 [PubMed - as supplied by publisher]
	Validation and clinical utility of predictive nomograms for sentinel node positivity in cutaneous malignant melanoma in Ireland. Surgeon Christodoulides N, Quirke N, Leon R, Ghinis A, Jeantet Q, Potter S. PMID: 41688298 [PubMed - as supplied by publisher]
	Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma. JCO Precis Oncol Ma VT, Zhou AY, Forati A, Hollnagel F, Patel JD, Burkey C, Steimle A, Sahasrabudhe DM, Mannino MC, Schehr JL, Birbrair A, Zhao SG, Lang JM, Victor AI. PMID: 41687044 [PubMed - indexed for MEDLINE]
	Potential mechanisms of Si-Wu-Tang against esophageal squamous cell carcinoma: A machine learning pharmacological study. Medicine (Baltimore) Li X, Zhang C, Li J, Yuan J, Xing T, Yang H, Shi H. PMID: 41686584 [PubMed - indexed for MEDLINE]
	Clinical Outcomes of Dacarbazine After Failure of Immune Checkpoint Inhibitors: A Case Study of 15 Japanese Patients With Malignant Melanoma. J Dermatol Horisaki K, Yoshikawa S, Omata W, Tsutsumida A, Kiyohara Y. PMID: 41685617 [PubMed - as supplied by publisher]
	Chorus line in oral squamous cell carcinoma: How stromal and immune players orchestrate tumor progression (Review). Int J Mol Med Cascardi E, Della Mura M, Sgarro N, Minei S, Cazzato G, Maiorano E, Lo Muzio L, Bizzoca ME, Vieira E Silva FF, Lo Muzio E, Dioguardi M, Ballini A. PMID: 41685581 [PubMed - indexed for MEDLINE]
	Spatially resolved tryptophan-kynurenine niches in HNSCC: immunometabolic microdomains and therapeutic implications. Front Immunol Ning W, Huang S. PMID: 41685324 [PubMed - indexed for MEDLINE]
	Prognostic impact of advanced lung cancer inflammation index and tumor load index in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy. Front Immunol Huang Y, Chen M, Yang Z, Zhang Y, Lin C, Zhang S, Zeng T, Yu J, Chen C, Zheng B. PMID: 41685309 [PubMed - indexed for MEDLINE]
	Circulating Tumor DNA in Melanoma: Advances in Detection, Clinical Applications, and Integration with Emerging Technologies. Int J Mol Sci Charbel N, Rizkallah J, Bal MN, El Masri A, Armache E, Ghezzawi M, Awada A, Kreidieh L, Mehdi J, Kreidieh F. PMID: 41683988 [PubMed - indexed for MEDLINE]
	Histological and Genetic Markers of Cellular Senescence in Keratinocyte Cancers and Actinic Keratosis: A Systematic Review. Int J Mol Sci Sobolewski P, Koper M, Wasaznik-Jedras A, Kolos M, Walecka I. PMID: 41683940 [PubMed - indexed for MEDLINE]
	The Role of Vitamins and Micronutrients in the Prevention of Melanoma: A Review of Current Evidence. Int J Mol Sci Pec J, Paj, Kleinrok J, Rusztyn K, Flieger J, Teresi, Forma A, Baj J. PMID: 41683849 [PubMed - indexed for MEDLINE]
	Biomarkers of Common Molecular Dysregulation in Tumor Tissue and Peritumor Mucosa in Head and Neck SCC: Insights into Field Cancerization. Int J Mol Sci Dimitrov L, Stancheva GS, Kyurkchiyan SG, Mitkova M, Stancheva I, Valcheva S, Komitova K, Skelina S, Rangachev J, Popov TM. PMID: 41683639 [PubMed - indexed for MEDLINE]
	Indocyanine Green (ICG) Fluorescence vs. Tc-99m Lymphoscintigraphy: Optimizing Sentinel Lymph Node Detection in Cutaneous Melanoma-A Systematic Review and Meta-Analysis. J Clin Med Matteucci M, Pesce A, Cirillo B, Zampino L, Masserano R, Guarino S, Properzi L, D'Andrea V, Cirocchi R. PMID: 41682825 [PubMed]
	Melanoma Presentations Before, During, and After the COVID-19 Pandemic: A Multicenter Cohort Study from North Rhine-Westphalia, Germany. Cancers (Basel) Gambichler T, Colo C, Weyer-Fahlbusch SS, Susok L, Boms S, Abu Rached N. PMID: 41682009 [PubMed]
	Current Treatment Standards for Metastatic Uveal Melanoma. Cancers (Basel) Rogala P, Czarnecka AM, Dudzisz-, Dawidowska A, Piwowarek KJ, Rutkowski P. PMID: 41681947 [PubMed]
	Impact of Dermatologic Screening and Methods on Breslow Thickness in Melanoma: A Retrospective Cohort Study. Cancers (Basel) Wunderlich K, Potiez A, Orte Cano C, Bouchat J, Van Damme N, Suppa M, White JM, Njimi H, Van Eycken E, Del Marmol V. PMID: 41681931 [PubMed]
	Uveal Melanoma: Biology, Prognostication, and Emerging Therapies to Outsmart an Immune-Cold Melanoma. Cancers (Basel) Brazel D, Buchbinder E. PMID: 41681903 [PubMed]
	ABCB5: A Key Regulator Linking Stem Cell Plasticity, Tumor Microenvironment, and Therapy Resistance in Cutaneous Melanoma. Cancers (Basel) Tinca AC, Sab, Cozac-Szoke AR, Chiorean DM, Lazar BA, Hag, Cocuz IG, Niculescu R, Kosovski IB, Muntean ST, Turdean SG, Cotoi OS. PMID: 41681896 [PubMed]

Articles 1 - 20 / 141407

Page 1 of 7071



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy